Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec;81(7):1122–1126. doi: 10.1038/sj.bjc.6690818

Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma

G L Wang 1, K W Lo 1, K S Tsang 1, N Y F Chung 1, Y S Tsang 1, S T Cheung 1, J C K Lee 1, D P Huang 1
PMCID: PMC2374319  PMID: 10584871

Abstract

The p16 gene, encodes a key checkpoint protein p16 in the cell cycle, has been reported inactivation in a wide variety of human cancers. We have previously demonstrated high frequency of p16 alterations in primary nasopharyngeal carcinoma (NPC), xenografts and cell lines. The finding implied that inactivation of the p16 gene may play an important role in the NPC development. To investigate the tumour suppressor function of p16 in NPC, we tranfected p16-deficient NPC cell line, NPC/HK-1, with a wild-type p16 expression construct, and evaluated growth and tumorigenic properties of the clones stably expressing exogenous p16. Expression of the exogenous wild-type p16 significantly inhibited cell growth by more than 70% when compared to that of the parental and empty vector-transfected cells. This growth inhibition was attributable to a significant proportion of p16-expressing cells arrested at G1 phase in the cell cycle as revealed by flow cytometric analysis. By anchorage-independent colony forming assay, we found that the ability to form colonies in soft agar was highly reduced in cells expressing p16. NPC/HK1 cells expressing functional p16 also showed suppressed tumorigenicity in athymic nude mice. Taken together, our results provide strong evidence for a tumour suppressor role of p16 in NPC. © 1999 Cancer Research Campaign

Keywords: nasopharyngeal carcinoma, p16, tumour suppressor, gene transfer

Full Text

The Full Text of this article is available as a PDF (113.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castellano M., Gabrielli B. G., Hussussian C. J., Dracopoli N. C., Hayward N. K. Restoration of CDKN2A into melanoma cells induces morphologic changes and reduction in growth rate but not anchorage-independent growth reversal. J Invest Dermatol. 1997 Jul;109(1):61–68. doi: 10.1111/1523-1747.ep12276538. [DOI] [PubMed] [Google Scholar]
  2. Chan F. K., Zhang J., Cheng L., Shapiro D. N., Winoto A. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol Cell Biol. 1995 May;15(5):2682–2688. doi: 10.1128/mcb.15.5.2682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cheng Y., Poulos N. E., Lung M. L., Hampton G., Ou B., Lerman M. I., Stanbridge E. J. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3042–3047. doi: 10.1073/pnas.95.6.3042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fueyo J., Gomez-Manzano C., Yung W. K., Clayman G. L., Liu T. J., Bruner J., Levin V. A., Kyritsis A. P. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene. 1996 Jan 4;12(1):103–110. [PubMed] [Google Scholar]
  5. Gulley M. L., Nicholls J. M., Schneider B. G., Amin M. B., Ro J. Y., Geradts J. Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. Am J Pathol. 1998 Apr;152(4):865–869. [PMC free article] [PubMed] [Google Scholar]
  6. Hannon G. J., Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994 Sep 15;371(6494):257–261. doi: 10.1038/371257a0. [DOI] [PubMed] [Google Scholar]
  7. Hinds P. W., Mittnacht S., Dulic V., Arnold A., Reed S. I., Weinberg R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992 Sep 18;70(6):993–1006. doi: 10.1016/0092-8674(92)90249-c. [DOI] [PubMed] [Google Scholar]
  8. Huang D. P., Ho J. H., Poon Y. F., Chew E. C., Saw D., Lui M., Li C. L., Mak L. S., Lai S. H., Lau W. H. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer. 1980 Aug;26(2):127–132. doi: 10.1002/ijc.2910260202. [DOI] [PubMed] [Google Scholar]
  9. Huang D. P., Lo K. W., Choi P. H., Ng A. Y., Tsao S. Y., Yiu G. K., Lee J. C. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet. 1991 Jul 1;54(1):91–99. doi: 10.1016/0165-4608(91)90035-s. [DOI] [PubMed] [Google Scholar]
  10. Huang D. P., Lo K. W., van Hasselt C. A., Woo J. K., Choi P. H., Leung S. F., Cheung S. T., Cairns P., Sidransky D., Lee J. C. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res. 1994 Aug 1;54(15):4003–4006. [PubMed] [Google Scholar]
  11. Hui A. B., Lo K. W., Leung S. F., Choi P. H., Fong Y., Lee J. C., Huang D. P. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res. 1996 Jul 15;56(14):3225–3229. [PubMed] [Google Scholar]
  12. Jin X., Nguyen D., Zhang W. W., Kyritsis A. P., Roth J. A. Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. Cancer Res. 1995 Aug 1;55(15):3250–3253. [PubMed] [Google Scholar]
  13. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., 3rd, Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994 Apr 15;264(5157):436–440. doi: 10.1126/science.8153634. [DOI] [PubMed] [Google Scholar]
  14. Kato J., Matsushime H., Hiebert S. W., Ewen M. E., Sherr C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993 Mar;7(3):331–342. doi: 10.1101/gad.7.3.331. [DOI] [PubMed] [Google Scholar]
  15. Li J. H., Li P., Klamut H., Liu F. F. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines. Clin Cancer Res. 1997 Apr;3(4):507–514. [PubMed] [Google Scholar]
  16. Liggett W. H., Jr, Sewell D. A., Rocco J., Ahrendt S. A., Koch W., Sidransky D. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res. 1996 Sep 15;56(18):4119–4123. [PubMed] [Google Scholar]
  17. Lo K. W., Cheung S. T., Leung S. F., van Hasselt A., Tsang Y. S., Mak K. F., Chung Y. F., Woo J. K., Lee J. C., Huang D. P. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res. 1996 Jun 15;56(12):2721–2725. [PubMed] [Google Scholar]
  18. Lo K. W., Huang D. P., Lau K. M. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res. 1995 May 15;55(10):2039–2043. [PubMed] [Google Scholar]
  19. Lo K., Huang P. W., Lee C. K. Genetic changes in nasopharyngeal carcinoma. Chin Med J (Engl) 1997 Jul;110(7):548–549. [PubMed] [Google Scholar]
  20. Lu Q. L., Elia G., Lucas S., Thomas J. A. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer. 1993 Jan 2;53(1):29–35. doi: 10.1002/ijc.2910530107. [DOI] [PubMed] [Google Scholar]
  21. Miyakoshi J., Kitagawa K., Yamagishi N., Ohtsu S., Day R. S., 3rd, Takebe H. Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene. Jpn J Cancer Res. 1997 Jan;88(1):34–38. doi: 10.1111/j.1349-7006.1997.tb00298.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994 Apr 21;368(6473):753–756. doi: 10.1038/368753a0. [DOI] [PubMed] [Google Scholar]
  23. Pagano M., Pepperkok R., Lukas J., Baldin V., Ansorge W., Bartek J., Draetta G. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol. 1993 Apr;121(1):101–111. doi: 10.1083/jcb.121.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Porter M. J., Field J. K., Leung S. F., Lo D., Lee J. C., Spandidos D. A., van Hasselt C. A. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol. 1994 Jan;114(1):105–109. doi: 10.3109/00016489409126025. [DOI] [PubMed] [Google Scholar]
  25. Quesnel B., Preudhomme C., Lepelley P., Hetuin D., Vanrumbeke M., Bauters F., Velu T., Fenaux P. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation. Br J Haematol. 1996 Nov;95(2):291–298. doi: 10.1046/j.1365-2141.1996.d01-1913.x. [DOI] [PubMed] [Google Scholar]
  26. Spillare E. A., Okamoto A., Hagiwara K., Demetrick D. J., Serrano M., Beach D., Harris C. C. Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfected p16INK4. Mol Carcinog. 1996 May;16(1):53–60. doi: 10.1002/(SICI)1098-2744(199605)16:1<53::AID-MC7>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  27. Spruck C. H., 3rd, Tsai Y. C., Huang D. P., Yang A. S., Rideout W. M., 3rd, Gonzalez-Zulueta M., Choi P., Lo K. W., Yu M. C., Jones P. A. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res. 1992 Sep 1;52(17):4787–4790. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES